198 related articles for article (PubMed ID: 28372583)
1. Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study.
Fedirko V; Tran HQ; Gewirtz AT; Stepien M; Trichopoulou A; Aleksandrova K; Olsen A; Tjønneland A; Overvad K; Carbonnel F; Boutron-Ruault MC; Severi G; Kühn T; Kaaks R; Boeing H; Bamia C; Lagiou P; Grioni S; Panico S; Palli D; Tumino R; Naccarati A; Peeters PH; Bueno-de-Mesquita HB; Weiderpass E; Castaño JM; Barricarte A; Sánchez MJ; Dorronsoro M; Quirós JR; Agudo A; Sjöberg K; Ohlsson B; Hemmingsson O; Werner M; Bradbury KE; Khaw KT; Wareham N; Tsilidis KK; Aune D; Scalbert A; Romieu I; Riboli E; Jenab M
BMC Med; 2017 Apr; 15(1):72. PubMed ID: 28372583
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL-HBV and REVEAL-HCV cohort studies.
Petrick JL; Florio AA; Zen J; Wang Y; Gewirtz AT; Pfeiffer RM; Loftus S; Inglefield J; Koshiol J; Yang B; Yu K; Hildesheim A; Chen CJ; Yang HI; Lee MH; McGlynn KA
Int J Cancer; 2023 Jul; 153(1):44-53. PubMed ID: 36878686
[TBL] [Abstract][Full Text] [Related]
3. Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.
Kong SY; Tran HQ; Gewirtz AT; McKeown-Eyssen G; Fedirko V; Romieu I; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Bastide N; Affret A; Kühn T; Kaaks R; Boeing H; Aleksandrova K; Trichopoulou A; Kritikou M; Vasilopoulou E; Palli D; Krogh V; Mattiello A; Tumino R; Naccarati A; Bueno-de-Mesquita HB; Peeters PH; Weiderpass E; Quirós JR; Sala N; Sánchez MJ; Castaño JM; Barricarte A; Dorronsoro M; Werner M; Wareham NJ; Khaw KT; Bradbury KE; Freisling H; Stavropoulou F; Ferrari P; Gunter MJ; Cross AJ; Riboli E; Bruce WR; Jenab M
Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):291-301. PubMed ID: 26823475
[TBL] [Abstract][Full Text] [Related]
4. Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome.
Ziegler TR; Luo M; Estívariz CF; Moore DA; Sitaraman SV; Hao L; Bazargan N; Klapproth JM; Tian J; Galloway JR; Leader LM; Jones DP; Gewirtz AT
Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R402-10. PubMed ID: 18003793
[TBL] [Abstract][Full Text] [Related]
5. Bacterial Translocation and Risk of Liver Cancer in a Finnish Cohort.
Yang B; Petrick JL; Thistle JE; Pinto LA; Kemp TJ; Tran HQ; Gewirtz AT; Waterboer T; Fedirko V; Jenab M; Graubard BI; Weinstein SJ; Albanes D; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2019 Apr; 28(4):807-813. PubMed ID: 30602499
[TBL] [Abstract][Full Text] [Related]
6. Elevations in serum anti-flagellin and anti-LPS Igs are related to growth faltering in young Tanzanian children.
McDonald CM; Manji KP; Gosselin K; Tran H; Liu E; Kisenge R; Aboud S; Fawzi WW; Gewirtz AT; Duggan CP
Am J Clin Nutr; 2016 Jun; 103(6):1548-54. PubMed ID: 27121948
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-flagellin and anti-lipopolysaccharide immunoglobulins as predictors of linear growth faltering in Pakistani infants at risk for environmental enteric dysfunction.
Syed S; Iqbal NT; Sadiq K; Ma JZ; Akhund T; Xin W; Moore SR; Liu E; Qureshi S; Gosselin K; Gewirtz A; Duggan CP; Ali SA
PLoS One; 2018; 13(3):e0193768. PubMed ID: 29509790
[TBL] [Abstract][Full Text] [Related]
8. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition.
Aleksandrova K; Bamia C; Drogan D; Lagiou P; Trichopoulou A; Jenab M; Fedirko V; Romieu I; Bueno-de-Mesquita HB; Pischon T; Tsilidis K; Overvad K; Tjønneland A; Bouton-Ruault MC; Dossus L; Racine A; Kaaks R; Kühn T; Tsironis C; Papatesta EM; Saitakis G; Palli D; Panico S; Grioni S; Tumino R; Vineis P; Peeters PH; Weiderpass E; Lukic M; Braaten T; Quirós JR; Luján-Barroso L; Sánchez MJ; Chilarque MD; Ardanas E; Dorronsoro M; Nilsson LM; Sund M; Wallström P; Ohlsson B; Bradbury KE; Khaw KT; Wareham N; Stepien M; Duarte-Salles T; Assi N; Murphy N; Gunter MJ; Riboli E; Boeing H; Trichopoulos D
Am J Clin Nutr; 2015 Dec; 102(6):1498-508. PubMed ID: 26561631
[TBL] [Abstract][Full Text] [Related]
9. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
Nagayama R; Miyake K; Tsuda F; Okamoto H
J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
[TBL] [Abstract][Full Text] [Related]
10. Dairy products and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition.
Duarte-Salles T; Fedirko V; Stepien M; Trichopoulou A; Bamia C; Lagiou P; Lukanova A; Trepo E; Overvad K; Tjønneland A; Halkjaer J; Boutron-Ruault MC; Racine A; Cadeau C; Kühn T; Aleksandrova K; Trichopoulos D; Tsiotas K; Boffetta P; Palli D; Pala V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita HB; Dik VK; Peeters PH; Weiderpass E; Torhild Gram I; Hjartåker A; Ramón Quirós J; Fonseca-Nunes A; Molina-Montes E; Dorronsoro M; Navarro Sanchez C; Barricarte A; Lindkvist B; Sonestedt E; Johansson I; Wennberg M; Khaw KT; Wareham N; Travis RC; Romieu I; Riboli E; Jenab M
Int J Cancer; 2014 Oct; 135(7):1662-72. PubMed ID: 24615266
[TBL] [Abstract][Full Text] [Related]
11. Soluble immune complexes and immunoglobulin (IgG, IgA and IgM) levels in Nigerians with primary liver cell carcinoma.
Olubuyide IO; Salimonu LS; Adeniran SO
Afr J Med Med Sci; 1993 Dec; 22(4):57-62. PubMed ID: 7839931
[TBL] [Abstract][Full Text] [Related]
12. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
[TBL] [Abstract][Full Text] [Related]
13. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.
Fedirko V; Duarte-Salles T; Bamia C; Trichopoulou A; Aleksandrova K; Trichopoulos D; Trepo E; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Kvaskoff M; Kühn T; Lukanova A; Boeing H; Buijsse B; Klinaki E; Tsimakidi C; Naccarati A; Tagliabue G; Panico S; Tumino R; Palli D; Bueno-de-Mesquita HB; Siersema PD; Peters PH; Lund E; Brustad M; Olsen KS; Weiderpass E; Zamora-Ros R; Sánchez MJ; Ardanaz E; Amiano P; Navarro C; Quirós JR; Werner M; Sund M; Lindkvist B; Malm J; Travis RC; Khaw KT; Stepien M; Scalbert A; Romieu I; Lagiou P; Riboli E; Jenab M
Hepatology; 2014 Oct; 60(4):1222-30. PubMed ID: 24644045
[TBL] [Abstract][Full Text] [Related]
14. Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma.
Butler LM; Arning E; Wang R; Bottiglieri T; Govindarajan S; Gao YT; Yuan JM
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1884-93. PubMed ID: 23897582
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum testosterone levels and risk of hepatocellular carcinoma.
Yu MW; Chen CJ
Cancer Res; 1993 Feb; 53(4):790-4. PubMed ID: 8381328
[TBL] [Abstract][Full Text] [Related]
16. Detection of Circulating Antibodies to p16 Protein-Derived Peptides in Hepatocellular Carcinoma.
Xu Y; Gu L; Wang J; Wang Z; Zhang P; Zhang X
Lab Med; 2020 Nov; 51(6):574-578. PubMed ID: 32195537
[TBL] [Abstract][Full Text] [Related]
17. Calreticulin is a B cell molecular target in some gastrointestinal malignancies.
Pekáriková A; Sánchez D; Palová-Jelínková L; Simsová M; Benes Z; Hoffmanová I; Drastich P; Janatková I; Mothes T; Tlaskalová-Hogenová H; Tucková L
Clin Exp Immunol; 2010 May; 160(2):215-22. PubMed ID: 20030668
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A, Vitamin E or beta-carotene status and hepatitis B-related hepatocellular carcinoma.
Pan WH; Wang CY; Huang SM; Yeh SY; Lin WG; Lin DI; Liaw YF
Ann Epidemiol; 1993 May; 3(3):217-24. PubMed ID: 8275192
[TBL] [Abstract][Full Text] [Related]
19. Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma.
Stepien M; Lopez-Nogueroles M; Lahoz A; Kühn T; Perlemuter G; Voican C; Ciocan D; Boutron-Ruault MC; Jansen E; Viallon V; Leitzmann M; Tjønneland A; Severi G; Mancini FR; Dong C; Kaaks R; Fortner RT; Bergmann MM; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita HB; Skeie G; Merino S; Ros RZ; Sánchez MJ; Amiano P; Huerta JM; Barricarte A; Sjöberg K; Ohlsson B; Nyström H; Werner M; Perez-Cornago A; Schmidt JA; Freisling H; Scalbert A; Weiderpass E; Christakoudi S; Gunter MJ; Jenab M
Int J Cancer; 2022 Apr; 150(8):1255-1268. PubMed ID: 34843121
[TBL] [Abstract][Full Text] [Related]
20. Serum IL27 in Relation to Risk of Hepatocellular Carcinoma in Two Nested Case-Control Studies.
Yuan JM; Wang Y; Wang R; Luu HN; Adams-Haduch J; Koh WP; Gao YT; Behari J; Lotze MT
Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):388-395. PubMed ID: 33203693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
